Get the Stockscreener App
1.73
2.37%
0.04
After Hours:
1.73
Trinity Biotech Plc Adr Stock (TRIB) Forecast
The Trinity Biotech Plc Adr (TRIB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.1848, representing a -89.32% decrease from the current price of $1.73. The highest analyst price target is $0.2994, and the lowest is $0.0702.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TRIB Price Target
Average 1.2717
(-26.49% Downside)
Is Trinity Biotech Plc Adr (TRIB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.37 | Neutral |
| STOCH(9,6) | 39.09 | Neutral |
| STOCHRSI(14) | 14.99 | Buy |
| MACD(12,26) | 0.0471 | Sell |
| ADX(14) | 20.42 | Neutral |
| William %R | -69.57 | Neutral |
| CCI(14) | -19.84 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.827
Sell
|
1.7737
Sell
|
| MA20 |
1.7819
Sell
|
1.7342
Sell
|
| MA50 |
1.632
Buy
|
1.77
Sell
|
| MA100 |
2.1106
Sell
|
1.9221
Sell
|
| MA200 |
2.0988
Sell
|
2.2019
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, TRIB could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on TRIB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 50.37 indicates that TRIB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.09 indicates that TRIB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 14.99 indicates that TRIB is oversold. This suggests that TRIB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.42 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -19.84 indicates that TRIB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TRIB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Trinity Biotech Plc Adr financial reports and earnings history, Trinity Biotech Plc Adr (TRIB) stock could reach $1.0436 by 2030, $0.8986 by 2040 and $2.3458 by 2050. See the projected annual prices until 2050 of the Trinity Biotech Plc Adr stock below:
- Trinity Biotech Plc Adr (TRIB) is expected to reach an average price of $0.7716 in 2035, with a high prediction of $0.7366 and a low estimate of $0.7319. This indicates an $-55.40% rise from the last recorded price of $1.73.
- Trinity Biotech Plc Adr (TRIB) stock is projected to chart a bullish course in 2040, with an average price target of $0.7858, representing an $-54.58% surge from its current level. The forecast ranges from a conservative $0.8906 to a sky-high $0.8986.
- Our analysts predict Trinity Biotech Plc Adr (TRIB) to jump -21.25% by 2045, soaring from $1.4623 to an average price of $1.3624, potentially reaching $1.3687. While $1.4623 is the low estimate, the potential upside is significant.
- Trinity Biotech Plc Adr (TRIB) stock is expected to climb by 2050, reaching an average of $2.2914, a $32.45% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.3458 and $2.3647, respectively, highlighting the market's uncertainty.
Trinity Biotech Plc Adr Stock (TRIB) Year by Year Forecast
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2024
Our forecast for TRIB stock price in 2024 now indicates an average price target of $1.3124 with a high forecast of $2.60 and a low forecast of $0.0248. The average prediction reflects an decrease of -24.14% from the last recorded price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.1994 | $0.0702 | $0.2994 | -88.48% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2025
Trinity Biotech Plc Adr Stock (TRIB) is expected to reach an average price of $1.2717 in 2025, with a high prediction of $2.5188 and a low estimate of $0.0246. This indicates an -26.49% fall from the last recorded price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.2938 | $0.131 | $0.3138 | -83.02% |
| February, 2025 | $0.4642 | $0.2168 | $1.0065 | -73.17% |
| March, 2025 | $0.6659 | $0.1256 | $0.8909 | -61.51% |
| April, 2025 | $0.2954 | $0.0246 | $1.1118 | -82.93% |
| May, 2025 | $0.3902 | $0.0763 | $0.5031 | -77.44% |
| June, 2025 | $0.7325 | $0.4348 | $1.2298 | -57.66% |
| July, 2025 | $1.327 | $0.4443 | $1.477 | -23.30% |
| August, 2025 | $1.9005 | $1.0678 | $2.0605 | +9.86% |
| September, 2025 | $1.8741 | $1.3932 | $2.5188 | +8.33% |
| October, 2025 | $1.1785 | $0.8167 | $1.975 | -31.88% |
| November, 2025 | $1.2721 | $1.0394 | $1.5912 | -26.47% |
| December, 2025 | $1.9765 | $1.073 | $2.3456 | +14.25% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2026
The predicted value for Trinity Biotech Plc Adr (TRIB) in 2026 is set at an average of $3.5676. Estimates vary from a peak of $6.0922 to a trough of $1.043, indicating an +106.22% surge from the present price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.6801 | $1.7983 | $3.7201 | +112.72% |
| February, 2026 | $3.6437 | $3.2328 | $4.201 | +110.62% |
| March, 2026 | $3.2872 | $2.7563 | $3.866 | +90.01% |
| April, 2026 | $5.0317 | $3.2558 | $6.0922 | +190.85% |
| May, 2026 | $3.9752 | $3.1034 | $5.3734 | +129.78% |
| June, 2026 | $3.0288 | $2.3961 | $3.9781 | +75.07% |
| July, 2026 | $2.6832 | $2.2132 | $3.2897 | +55.10% |
| August, 2026 | $2.5168 | $2.335 | $3.0249 | +45.48% |
| September, 2026 | $1.7812 | $1.5012 | $2.6294 | +2.96% |
| October, 2026 | $1.6648 | $1.043 | $1.8839 | -3.77% |
| November, 2026 | $1.9084 | $1.3566 | $2.1875 | +10.31% |
| December, 2026 | $1.4228 | $1.3328 | $2.3501 | -17.76% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Trinity Biotech Plc Adr (TRIB) is $0.9957, with a high forecast of $1.8046 and a low forecast of $0.1868. This indicates an -42.44% decrease from the last price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.3764 | $1.2546 | $1.8046 | -20.44% |
| February, 2027 | $1.2699 | $1.2199 | $1.4573 | -26.59% |
| March, 2027 | $0.9044 | $0.7144 | $1.3035 | -47.72% |
| April, 2027 | $0.7029 | $0.5279 | $0.9253 | -59.37% |
| May, 2027 | $0.4915 | $0.4297 | $0.7088 | -71.59% |
| June, 2027 | $0.3457 | $0.3259 | $0.5424 | -80.01% |
| July, 2027 | $0.3895 | $0.1868 | $0.4695 | -77.49% |
| August, 2027 | $0.4131 | $0.2363 | $0.8822 | -76.12% |
| September, 2027 | $0.7175 | $0.3788 | $0.7875 | -58.53% |
| October, 2027 | $0.6111 | $0.4611 | $0.8162 | -64.68% |
| November, 2027 | $0.6846 | $0.4329 | $0.7546 | -60.43% |
| December, 2027 | $0.7591 | $0.5873 | $0.8455 | -56.12% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2028
In 2028, Trinity Biotech Plc Adr (TRIB) is projected to reach an average price of $0.4886, with a high projection of $0.79 and a low estimate of $0.1872. This indicates an -71.76% fall from the last price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5426 | $0.4626 | $0.79 | -68.63% |
| February, 2028 | $0.4272 | $0.2953 | $0.6554 | -75.31% |
| March, 2028 | $0.5207 | $0.4436 | $0.6371 | -69.90% |
| April, 2028 | $0.6942 | $0.4815 | $0.7745 | -59.87% |
| May, 2028 | $0.4087 | $0.3787 | $0.7651 | -76.38% |
| June, 2028 | $0.4622 | $0.2896 | $0.5704 | -73.28% |
| July, 2028 | $0.4958 | $0.3962 | $0.5331 | -71.34% |
| August, 2028 | $0.3502 | $0.3203 | $0.5576 | -79.76% |
| September, 2028 | $0.2286 | $0.1913 | $0.3611 | -86.79% |
| October, 2028 | $0.4123 | $0.1872 | $0.6256 | -76.16% |
| November, 2028 | $0.3718 | $0.2491 | $0.4282 | -78.51% |
| December, 2028 | $0.3465 | $0.2927 | $0.4936 | -79.97% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2029
The 2029 price forecast for Trinity Biotech Plc Adr Stock (TRIB) is $1.0294 on average, with a high prediction of $2.031 and a low estimate of $0.0278. This represents an -40.50% decrease from the previous price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3498 | $0.0278 | $0.4962 | -79.78% |
| February, 2029 | $0.1264 | $0.0716 | $0.3907 | -92.70% |
| March, 2029 | $0.1279 | $0.0943 | $0.3245 | -92.61% |
| April, 2029 | $0.0655 | $0.0487 | $0.1978 | -96.21% |
| May, 2029 | $0.1624 | $0.1136 | $0.1118 | -90.61% |
| June, 2029 | $0.0715 | $0.1515 | $0.1533 | -95.87% |
| July, 2029 | $0.1489 | $0.1006 | $0.1279 | -91.39% |
| August, 2029 | $0.0165 | $0.1403 | $0.1179 | -99.05% |
| September, 2029 | $1.8301 | $0.0726 | $1.8301 | +5.78% |
| October, 2029 | $1.5545 | $1.5127 | $2.031 | -10.14% |
| November, 2029 | $1.2435 | $1.2281 | $1.6554 | -28.12% |
| December, 2029 | $0.93 | $0.885 | $1.4095 | -46.24% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2030
Trinity Biotech Plc Adr Stock (TRIB) is expected to reach an average price of $0.5372 in 2030, with a high forecast of $1.0436 and a low forecast of $0.0308. This signifies an -68.95% decrease from the last price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1239 | $0.1189 | $1.0436 | -92.84% |
| February, 2030 | $0.781 | $0.0308 | $0.8242 | -54.85% |
| March, 2030 | $0.5731 | $0.4446 | $0.9908 | -66.87% |
| April, 2030 | $0.2556 | $0.0511 | $0.5649 | -85.22% |
| May, 2030 | $0.3908 | $0.338 | $0.3658 | -77.41% |
| June, 2030 | $0.8714 | $0.4791 | $0.7937 | -49.63% |
| July, 2030 | $0.5948 | $0.6863 | $0.7959 | -65.62% |
| August, 2030 | $0.6177 | $0.5995 | $0.5827 | -64.29% |
| September, 2030 | $0.5303 | $0.5424 | $0.4806 | -69.35% |
| October, 2030 | $0.5917 | $0.5152 | $0.4988 | -65.80% |
| November, 2030 | $0.5146 | $0.601 | $0.5399 | -70.26% |
| December, 2030 | $0.557 | $0.6974 | $0.671 | -67.80% |
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):